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Introduction
Asymptomatic oral Candida	 carriage has been shown 
to be much more common in HIV-seropositive subjects 
than in healthy subjects [1-3]. It is also known that 
oropharyngeal candidiasis is the most common oppor-
tunistic infection in AIDS patients [4, 5]. Although 
different species of Candida, such as C.	 glabrata,	 C.	
tropicalis,	 C.	 krusey,	 and C.	 dubliniensis, are at pre-
sent recognized as increasing opportunistic pathogens 
specially in immunocompromised patients, C.	albicans	
still remains the most common fungus isolated in hu-
mans [6-8]. The frequency of isolation of C.	 albicans	
and the clinical recurrence of oral candidiasis increase 
with advancing the HIV infection, so that up to 90% of 
infected individuals suffer from at least one episode of 
oropharingeal candidiasis during the course of the disea-
se [2, 9]. Infections may be acquired from endogenous 
flora (e.g. commensal fungi that colonize oropharynx, 
genitourinary tract, gut, or skin) and clinical lesions of 
oropharyngeal or oesophageal candidiasis can develop 
as the HIV infection progresses [2, 10]. 
A prospective study conducted with HIV-infected su-
bjects with and without symptoms of oropharingeal 
candidiasis revealed that although some patients main-
tained the identical C.	 albicans isotype on contiguous 
sequential visits, in others this occurred irregularly, yet 
periodically [11]. More recently, it has been reported 
that	 strains of C.	 albicans from AIDS patients with 
oral candidiasis were genetically less diverse than oral 
commensal isolates from patients with no signs of oral 
thrush at the time of the sampling, possibly because 
more resistant and hence stable strains were acquired 
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during recurrent infections and multiple course of anti-
microbial treatment [12]. The same studies indicate that 
C.	 albicans populations in patients with HIV exhibit 
genetic reshuffling. on the other hand, the persistence 
of the same DNA subtypes of C.	 albicans throughout 
each episode of infection during a long period of obser-
vation has been reported in four of five AIDS patients 
undergoing fluconazole therapy [9]. Despite exposure 
to antifungal drugs has no effect on the level of yeast 
carriage in HIV-positive patients [13], there is evidence 
that appropriate prophylactic use of antifungal agents 
reduce the clinical signs of candidiasis in patients with 
impaired immunitary conditions [14].
In Italy, isolation of Candida	spp. from the oral cavity 
of patients infected by HIV has been reported by Cam-
pisi	 et al.	 (2002) [1] but the duration of the carriage 
status and the genotypes of the isolates have not been 
defined. Furthermore, no investigations on the status 
of urinary carriage have been reported in HIV-positive 
subjects. Therefore, the purpose of this study was to 
ascertain the frequency and the persistence of Candida	
spp. oral and urinary carriage in asymptomatic HIV-
seropositive Italian subjects who had not undergone 
therapy with antimycotic drugs and with no prior hi-
story of thrush. 
Materials and methods
Isolation and identification of Candida spp. 
from patients
Swabs from the oral cavity and urine samples were 
collected from 46 HAART-naive HIV-seropositive sub-
Summary
The aim of the present study was to ascertain frequency and 
persistence of Candida spp. oral and urinary carriage in 
asymptomatic, HAART-naive HIV-seropositive subjects who 
had not undergone therapy with antimycotic drugs, and whose 
CD4+ lymphocyte count was greater than 200/µl. Oral carriage 
was the most common Candida spp. carriage (63.0% of the 
subjects), while candiduria was more rarely observed (6.5%). 
C. albicans was recovered from the majority of the subjects 
examined (56.5%), followed by C. krusey (4.3%), C. tropicalis 
(2.2%) and C. dubliniensis (2.2%). C. albicans was also iso-
lated from two urinary carriers (4.3%) and C. glabrata from 
another one (2.2%). The same C. albicans clone was repeatedly 
isolated from 14 out of 15 oral carriers while the same clone 
of C. dubliniensis was repeatedly isolated from one carrier, as 
shown by the persistence of RAPD fingerprint of serial isolates 
during one year of follow-up. Since persistence of Candida spp. 
carriage may influence the development of clinical candidiasis 
in immunocompromised hosts, monitoring of the carrier status 
could be useful for preventing clinical thrush in HIV-seroposi-
tive subjects.
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jects (40 men and 6 women) confirmed by ELISA and 
Western blot, attendant at regular intervals the Com-
municable Diseases Division of a General Hospital in 
Catania (Sicily, Italy). At the time of the sampling, all 
subjects were asymptomatic for Candida infections and 
had their CD4+ lymphocyte counts greater than 200/µl. 
The study was approved by the Bioethics Committee of 
the Hospital. All subjects provided informed consent be-
fore the recruitment. Oral swabs and urine samples were 
collected from 16 subjects at intervals varying from 1 
to 6 months over one year time period. The swabs and 
100 microlitre quantities of urine from each subject 
were plated, respectively, onto plates of CHROMagar 
Candida (Becton Dickinson, New Jersey, USA) and 
incubated at 37°C for 48-72 h. 
Presumptive identification of isolates was attempted on 
the basis of the characteristic colouration of the colonies 
on CHROMagar Candida. All isolates were purified 
by subculturing on Sabouraud glucose agar (Oxoid, 
Hampshire, England) and identified to the species level 
by carbohydrate assimilation profiles obtained by two 
commercial systems: API ID 32 C and API 20 C AUX 
(both BioMérieux, Marcy-l’Etoile, France). The isolates 
suspected to be C. albicans were also studied for germ-
tube formation in human serum incubated at 37°C for 2 
h. Isolates showing carbohydrate assimilation profiles 
of C. dubliniensis were confirmed by intracellular 
β-glucosidase test, incubation at 42°C, and karyotyp-
ing [15, 16].
Genotyping of candida albicans and candida 
dubliniensis isolates
C. albicans and C. dubliniensis isolates from each car-
rier and their serial isolates were genotyped by RAPD 
fingerprinting, as previously described [17], in order 
to ascertain the persistence of the same genotype in 
the oral cavity and urine samples of the different carri-
ers. The DNA extraction was performed in accordance 
with Hoffman’s protocol (1993) [18]. The single repeat 
sequence (GACA)4 was used as primer in the PCR ex-
periments as described by Schonian et al. (1993) [19]. 
Briefly, 200 µM of each deoxinucleotide (Amersham 
Pharmacia Biotech, Uppsala, Sweden), 16 pmol primer, 
25 ng template DNA, 2.5 U Taq DNA polymerase 
(Perkin Elmer Corp., Applied Biosystems, New Jersey, 
USA), 10 mM Tris/HCl (pH 8.3), 50 mM KCl, 1.5 mM 
MgCl2, and 3 mM Mg-acetate were added to a 50 µl 
reaction volume. The cycle parameters were 33 cycles 
of 20 s at 94°C, 1 min at 43°C, 20 sec at 72°C, followed 
by a final extension cycle of 6 min at 72°C, performed 
on a Hybaid thermocycler (Teddington Middlesex, 
United Kingdom). The RAPD products were separated 
by electrophoresis through a 1.2% agarose gel in 0.5 
x TBE (89 mM Tris-borate, 2 mM EDTA) buffer at 2 
Volts/cm for 16 h. The gels were stained with ethid-
ium bromide and photographed. Lambda phage DNA 
digested with BstE II was used for the DNA fragments 
size determination. RAPD fingerprints were analysed 
by the Gel Compare software (Applied Maths BVBA, 
Kortrick, Belgium).
Results
Out of 46 HIV-subjects, 29 (63.0%) were positive for 
oral carriage of Candida (twenty-eight men and one 
woman) and 3 (6.5%) for urinary carriage (two men and 
one woman). The number of yeast colonies in the plates 
inoculated with the samples varied from 10 to > 300, 
according to the different subjects. None of them had 
lesions presumptive for candidiasis at the time of the 
sampling or developed oral lesions nor genitourinary 
troubles during the twelve months of follow-up. 
The most common species found in the oral cavity was 
C. albicans, isolated from 26 (56.5%) subjects, followed 
by C. krusey from two subjects (4.3%), C. tropicalis 
from one (2.2%) and C. dubliniensis from another one 
(2.2%). One of the two C. krusey isolates was recovered 
from a carrier of C. albicans (mixed culture). Species 
isolated from urines were C. albicans (two subjects, 
4.3%) and C. glabrata (one subject, 2.2%). C. albicans 
was cultured from both oral and urinary samples of the 
carrier woman.
Sixteen of the positive subjects under study (15 men and 
the positive woman) were submitted to further oral and 
urine sampling during one year of follow-up. Two to 
six serial isolates were obtained from the 14 men posi-
tive for C. albicans and two isolates each from the oral 
swabs and urines from the positive woman, for a total of 
43 serial isolates of C. albicans. Furthermore, six serial 
isolates at two months intervals were obtained from the 
oral carrier of C. dubliniensis.
Analysis of the C. albicans serial isolates using RAPD 
fingerprints with primer (GACA)4 originated 15 dif-
ferent patterns, while a further distinct pattern was 
obtained from the C. dubliniensis isolates. The same 
RAPD pattern was shown by the oral and urinary iso-
lates from the carrier woman. RAPD fingerprintings of 
41 C. albicans serial isolates from 14 out of 15 carriers 
showed persistence of the respective patterns throughout 
all the follow-up period. Only in one carrier the second 
isolate differed from the first one. The six isolates of C. 
dubliniensis obtained during the one year of follow-up 
also maintained the same RAPD pattern. 
Discussion and conclusions
Asymptomatic oropharyngeal carriage of Candida spp. 
is a common finding in HIV-infected patients. Costa et 
al. (2006) [3] found that out of 99 HIV-positive patients 
studied, 62 (62.6%) had positive culture for Candida 
(oral carriage). Similar prevalence had previously been 
reported by Campisi et al. (2002) [1], who found an 
oral Candida carriage rate of 61.9%, by Gugnani et al. 
(2003) [20], who discovered a proportion of 65.3% in 
HIV-seropositive subjects, and by Sanchez-Vargas et 
al. (2005) [21] that reported a Candida isolation rate of 
66.7% in HIV/AIDS patients. A similar high rate of oral 
carriage of Candida (63.0%) was detected in the HIV-
positive subjects monitored in our study. Moreover, 
according to the cited studies, the most common species 
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isolated in the oral cavity of the HIV-positive subjects 
examined was C. albicans (87.0%). 
Despite the high prevalence of C. albicans, some 
other species which have been generally isolated at 
minor frequency have proved to be present in the oral 
cavity of the immunocompromised patient popula-
tion [16, 21-24]. In our study, C. dubliniensis, in par-
ticular, showed to be a persistent commensal in one 
subject, while some other species (C. krusei, C. gla-
brata and C. tropicalis) were occasionally isolated.
Yeast colonization on oral mucosa is considered the 
precondition of oral candidiasis and early detection of 
oral carriage of Candida spp. is seen to be important 
for identification of patients with the propensity for 
rapid progression of HIV infection. Despite it has been 
shown that the status of oral Candida carrier is not 
associated with the number of CD4+ cells or the viral 
load [1, 3, 25, 26], little is known about the changes, if 
any, which may occur in C. albicans when asymptoma-
tic HIV-positive subjects develop clinically significant 
candidiasis. Also studies on molecular epidemiology 
of oral Candida spp. colonization have not completely 
elucidated what happens to Candida spp. strains carried 
by HIV-infected subjects in the transition from a heal-
thy carriage status to a disease status. The combined 
results of a number of studies monitoring HIV-infected 
subjects have shown different scenarios ranging from 
maintenance of genetically invariant strains to replace-
ment of commensal strains by unrelated strains [2]. In 
a preceding study on the discriminatory power of some 
phenotypic and molecular typing methods, RAPD C. al-
bicans fingerprinting was proved highly discriminatory 
and suitable for epidemiological studies [17]. Therefore, 
the persistence of the same RAPD patterns in the serial 
isolates throughout the follow-up period, as observed 
in 14 out of 15 C. albicans and in one C. dubliniensis 
carriers, suggests that the same strain can colonize for a 
long time the oral mucosa of HIV-infected subjects. 
To our knowledge, up to now no systematic investi-
gations on the frequency and persistence of candidal 
urinary carriage in asymptomatic HIV-positive subjects 
have been conducted. In our study, urinary carriage was 
detected in only three subjects (6.5%), two of which 
were colonized by C. albicans and the third one by C. 
glabrata. One of the two C. albicans urinary carrier was 
also oral carrier and his isolate belonged to the same 
RAPD type of the C. albicans isolate cultured from the 
oral swab. Further epidemiological investigations are 
needed to better determine the frequency of urinary can-
didial carriage and to understand its role in developing 
opportunistic infections in the urinary tract. 
In conclusion, a study of HIV-positive subjects asymp-
tomatic for candidiasis over a 1-year period allowed 
us to monitor the dynamics of Candida spp. oral and 
urinary colonization. Since persistence of carriage may 
influence the development of clinical candidiasis in 
HIV-positive subjects, monitoring the carrier status 
could be useful for preventing Candida spp. infections 
by topical or systemic antifungal drugs when CD4+T 
count falls under 200 cells/µl. Therefore, systematic 
oral and urinary examination for HIV-positive subjects 
should be recommended together with the survey of 
their immune status for better managing opportunistic 
infections in these patients.
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